REFERENCES
1. Philips CA, Rajesh S, Nair DC, Ahamed R, Abduljaleel JK, Augustine P.
Hepatocellular Carcinoma in 2021: An Exhaustive Update. Cureus.
2021;13(11):e19274.
2. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et
al. Cancer incidence and mortality worldwide: sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359-86.
3. Poudel KK, Huang Z, Neupane PR, Steel R. Changes in the Distribution
of Cancer Incidence in Nepal from 2003 to 2013. Asian Pac J Cancer Prev.
2016;17(10):4775-82.
4. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and
molecular carcinogenesis. Gastroenterology. 2007;132(7):2557-76.
5. Chidambaranathan-Reghupaty S, Fisher PB, Sarkar D. Hepatocellular
carcinoma (HCC): Epidemiology, etiology and molecular classification.
Adv Cancer Res. 2021;149:1-61.
6. Aljumah AA, Kuriry H, AlZunaitan M, Al Ghobain M, Al Muaikeel M, Al
Olayan A, et al. Clinical Presentation, Risk Factors, and Treatment
Modalities of Hepatocellular Carcinoma: A Single Tertiary Care Center
Experience. Gastroenterol Res Pract. 2016;2016:1989045.
7. Heimbach JK, Kulik LM, Finn RS, Sirlin CB, Abecassis MM, Roberts LR,
et al. AASLD guidelines for the treatment of hepatocellular carcinoma.
Hepatology. 2018;67(1):358-80.
8. Bruix J, Reig M, Sherman M. Evidence-Based Diagnosis, Staging, and
Treatment of Patients With Hepatocellular Carcinoma. Gastroenterology.
2016;150(4):835-53.
9. Shrestha A. Liver Cancer in Nepal. Euroasian J Hepatogastroenterol.
2018;8(1):63-5.
10. Kumar R, Saraswat MK, Sharma BC, Sakhuja P, Sarin SK.
Characteristics of hepatocellular carcinoma in India: a retrospective
analysis of 191 cases. QJM. 2008;101(6):479-85.
11. Musunuri B, Shetty S, Bhat G, Udupa K, Pai A. Profile of patients
with hepatocellular carcinoma: An experience from a tertiary care center
in India. Indian J Gastroenterol. 2022;41(2):127-34.
12. Vikas Jagtap LPD, Caleb Harris, Vandana Raphael. Clinical and
Epidemiological profile of Hepatocellular carcinoma (HCC): Retrospective
analysis from high incidence zone in North East India. The Journal of
Association of Surgeons of Assam. 2021;28(1):5.
13. Yang JD, Mohamed EA, Aziz AO, Shousha HI, Hashem MB, Nabeel MM, et
al. Characteristics, management, and outcomes of patients with
hepatocellular carcinoma in Africa: a multicountry observational study
from the Africa Liver Cancer Consortium. Lancet Gastroenterol Hepatol.
2017;2(2):103-11.
14. Rahman El-Zayadi A, Abaza H, Shawky S, Mohamed MK, Selim OE, Badran
HM. Prevalence and epidemiological features of hepatocellular carcinoma
in Egypt-a single center experience. Hepatol Res. 2001;19(2):170-9.
15. Shrestha SM, Subedi NB, Shrestha S, Maharjan KG, Tsuda F, Okamoto H.
Epidemiology of hepatitis C virus infection in Nepal. Trop
Gastroenterol. 1998;19(3):102-4.
16. Shrestha SM. Seroepidemiology of hepatitis B in Nepal. J Commun Dis.
1990;22(1):27-32.
17. Rizal S, Joshi BR, Singh AG. Burden of Alcoholic Liver Disease in a
Tertiary Care Center: A Descriptive Cross-sectional Study. JNMA J Nepal
Med Assoc. 2019;57(219):307-10.
18. Collier J, Sherman M. Screening for hepatocellular carcinoma.
Hepatology. 1998;27(1):273-8.
19. Bhatti ABH, Sheikh AAE, Mahmud US, Zeeshan S, Khan NY, Zia HH, et
al. Clinical Profile and Treatment of Hepatocellular Carcinoma: A
Single-Center Experience. South Asian J Cancer. 2021;10(2):76-80.
Table 1. Demographic profile of the patients (n = 54)